SCHEMBL40861

SCHEMBL40861

c1cnc2nn[nH]c2c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29376620 1.00
SCHEMBL27759739 0.98 NUDT1 (0.42)
SCHEMBL28611928 0.98 NUDT1 (0.42)
SCHEMBL8038689 0.98 NUDT1 (0.42)
Iodide SCHEMBL16585403 0.98 NUDT1 (0.42)
Hydrochloric Acid SCHEMBL29236109 0.98 NUDT1 (0.42)
SCHEMBL21990259 0.98 NUDT1 (0.42)
SCHEMBL29948103 0.94 NUDT1 (0.40)
Pyrazine SCHEMBL27939229 0.94 NUDT1 (0.40)
SCHEMBL937094 0.92 NUDT1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 10460 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122036726-A Preparation method of triazolopyridine compound 天津辰欣药物研究有限公司 2026-05-15 CN claimed
US-20260098196-A1 CHEMICAL-MECHANICAL POLISHING COMPOSITION FOR SILVER POLISHING ENTEGRIS INC (US) 2026-04-09 US claimed
EP-3915587-B1 IMPROVED CELL-TARGETING BINDING MOLECULE SAPREME TECH BV (NL) 2026-03-25 EP claimed
EP-3597184-B1 INDANONE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS OR OPTICAL ISOMERS THEREOF, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES KOREA RES INST CHEMICAL TECH (KR) 2026-03-04 EP claimed
EP-4688778-A1 1H-PYRROLO[2,3-B]PYRIDIN-4-YL]-2-OXOPYRROLIDINE-3-CARBONITRILE DERIVATIVES AS TYROSINE KINASE 2 (TYK2) INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES Biogen MA Inc. (US) 2026-02-11 EP claimed
US-12527741-B2 Modular dendron micelles for treatment of pulmonary diseases related to fibrosis and viral infection including COVID-19 WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2026-01-20 US claimed
EP-3831387-B1 NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF SAGE THERAPEUTICS LLC (US) 2026-01-14 EP claimed
EP-4654964-A1 SULFONE-1H-PYRROLE-2-CARBOXAMIDE INHIBITORS OF SARS-COV-2 NSP14 METHYLTRANSFERASE AND DERIVATIVES THEREOF The Rockefeller University (US) 2025-12-03 EP claimed
US-20250361432-A1 Slurry Composition for Chemical Mechanical Polishing KCTECH CO LTD (KR) 2025-11-27 US claimed
EP-4653437-A2 NOVEL HETEROCYCLIC COMPOUNDS Innovo Therapeutics Inc. (KR) 2025-11-26 EP claimed
EP-0128536-A1 Fluoromethylthiooxacephalosporin derivatives SHIONOGI & CO., LTD. (JP) 1984-12-19 EP claimed
EP-0025603-B1 TRIAZOLO (4,3-A)PYRIDIN-3(2H)-ONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Bristol-Myers Company (US) 1983-11-02 EP claimed
US-4411985-A TRIARYLPHOSPHINES OR TRIARYLPHOSPHORANES STABILIZERS EASTMAN KODAK COMPANY (US) 1983-10-25 US claimed
US-4351896-A Mesoionic silver halide stabilizer precursor and use in a heat developable and heat stabilizable photographic silver halide material and process EASTMAN KODAK COMPANY (US) 1982-09-28 US claimed
US-4302454-A Cephalosporins SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-11-24 US claimed
US-4266060-A ANTITUMOR ANTIVIRAL AGENTS FOR TREATMENT OF CANCER AGENCE NATIONALE DE VAL ORISATION DE LA RECHERCHE (ANVAR) (FR) 1981-05-05 US claimed
EP-0025603-A1 Triazolo (4,3-a)pyridin-3(2H)-ones, process for their preparation and pharmaceutical compositions containing them Bristol-Myers Company (US) 1981-03-25 EP claimed
US-4140531-A Light-handleable photographic materials MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1979-02-20 US claimed
US-4084969-A SILVER IODIDE, DEVELOPMENT IN PRESENCE OF TRIVALENT COBALT COMPLEX FUJI PHOTO FILM CO., LTD. (JA) 1978-04-18 US claimed
US-4011083-A SURFACE SENSITIVE SILVER HALIDE EMULSION CONTAINING A SILVER COMPLEXING AZAINDENE TO REDUCE DESENSITIZATION OF OPTICAL SENSITIZING DYE INCORPORATED THEREIN EASTMAN KODAK COMPANY (US) 1977-03-08 US claimed